# CELC PDUFA Calendar: FDA Decision Dates & Catalyst Timeline

Canonical URL: https://biopharmsignal.com/pdufa-calendar/CELC
Company: Celcuity

BioPharmSignal tracks active PDUFA and FDA decision milestones associated with CELC.

## CELC PDUFA Milestones

- 2026-07-17 — PDUFA — Gedatolisib + palbociclib + fulvestrant (gedatolisib triplet) treating HR+/HER2-/PIK3CA Wild-Type Advanced Breast Cancer (ABC)
  Company: Celcuity
  Month page: https://biopharmsignal.com/pdufa-calendar/2026/july (July 2026)

## Related Pages

- Company page: https://biopharmsignal.com/company/CELC
- Interactive PDUFA Calendar: https://biopharmsignal.com/pdufa-calendar

## FAQ

### What does the CELC PDUFA calendar show?

It shows active PDUFA and FDA decision milestones associated with CELC, including decision dates, application stage, and summary details when available.
### Where can I find more context for CELC?

Use the BioPharmSignal company page for CELC to read related news, stock data, sector context, and company-specific updates.
### Are these dates investment advice?

No. PDUFA dates are research inputs, not investment recommendations. Always review primary sources and understand the clinical and regulatory context.